Evidence map›Paper›PMID 42193951›Full record

ArticleCells2026

Disruption of Fructose 1,6-Bisphosphatase 2 Proximity to MIC60 Correlates with Mitochondrial Ultrastructural Changes.

Łukasz Pietras, Marta Migocka-Patrzałek, Bartosz Budziak, Dariusz Rakus, Agnieszka Gizak

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Łukasz PietrasDepartment of Molecular Physiology and Neurobiology, University of Wrocław, 50-335 Wrocław, Poland.ORCID 0000-0003-1652-6253
Marta Migocka-PatrzałekDepartment of Animal Developmental Biology, University of Wroclaw, 50-335 Wrocław, Poland.ORCID 0000-0003-0077-7779
Bartosz BudziakDepartment of Molecular Physiology and Neurobiology, University of Wrocław, 50-335 Wrocław, Poland.ORCID 0000-0003-3191-0050
Dariusz RakusDepartment of Molecular Physiology and Neurobiology, University of Wrocław, 50-335 Wrocław, Poland.ORCID 0000-0002-3511-0459
Agnieszka GizakDepartment of Molecular Physiology and Neurobiology, University of Wrocław, 50-335 Wrocław, Poland.ORCID 0000-0001-9367-0270

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fructose 1,6-bisphosphatase 2 (FBP2) is a multifunctional protein whose cellular functions depend on its oligomeric state. Forced FBP2 tetramerization has been linked to microtubule disruption and impaired mitochondrial trafficking, accompanied by abnormal mitochondrial morphology. Here, we identify MIC60 (mitofilin), a core element of the mitochondrial contact site and cristae organizing system (MICOS), as a potential mediator of these effects. Using proximity ligation assay, protein crosslinking combined with mass spectrometry, and ultrastructural analysis, we demonstrate that FBP2 is in close proximity to MIC60 under basal conditions and this proximity is reduced upon FBP2 tetramerization or partial FBP2 depletion. Loss of this proximity coincides with marked remodeling of inner-membrane ultrastructure. These findings are consistent with a working model in which dimeric FBP2 contributes to the coordination of microtubule-dependent mitochondrial positioning with MICOS-linked intramitochondrial organization, providing a plausible mechanistic bridge between metabolic cues (AMP/NAD

Indexed as

Fructose-BisphosphataseMitochondriaMitochondrial ProteinsAnimalsHumansMicrotubulesFructose-BisphosphataseMitochondrial ProteinscardiomyocyteFBP2MIC60mitochondriamitofilinultrastructure

Identifiers

PMID42193951
PMCPMC13204092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.